Enhancing Quality of Life in Cancer Patients Through Tailored Nutrition Support: a Comprehensive Approach
Launched by UOMI CANCER CENTER · Oct 2, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how personalized nutrition support can help improve the quality of life for patients with cancer. The researchers want to understand how a special nutritional assistance tool can benefit patients by measuring its effects on various health indicators. If you or a loved one is between the ages of 65 and 74, has been diagnosed with cancer, and expects to live for at least another year, you might be eligible to participate in this study.
To join the trial, participants need to agree to take part and sign an informed consent form. However, individuals with a history of eating disorders or other specific health issues may not be able to participate. If you join the study, you can expect to receive tailored nutritional guidance to help support your health during cancer treatment. This trial is currently recruiting participants, so it’s a great opportunity to explore how nutrition can play a role in cancer care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients affected by cancer, who decided to participate to the study, signed the informed consent and whose life expectancy is higher than 1 (one) year.
- Exclusion Criteria:
- • Patients with an eating disorder of psychiatric or psychological origin, diagnosed before cancer treatment.
- • Any other exclusion criteria as determined by the oncologist based on the patient's ability to successfully complete the program.
About Uomi Cancer Center
Uomi Cancer Center is a leading clinical research institution dedicated to advancing cancer treatment through innovative trials and comprehensive patient care. With a multidisciplinary team of experts, the center focuses on developing cutting-edge therapies and personalized medicine approaches, aiming to improve outcomes for cancer patients. Uomi Cancer Center prioritizes patient safety and ethical research practices while fostering collaboration with academic institutions and industry partners. Committed to enhancing the understanding and management of cancer, the center plays a pivotal role in the ongoing quest for effective treatment options and improved quality of life for those affected by cancer.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Barcelona, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported